Transversus Abdominis Plane (TAP) BlockTAPNCT06627946
Ultrasound-guided Transversus Abdominis Plane Block Versus Local Wound Infiltration (TAP_WI)
A study testing TAP group in people with Transversus Abdominis Plane (TAP) Block and Wound Infiltration, run by Ministry of Health, Bhutan at 1 site in Bhutan.
Trial summary
The goal of this clinical trial is to learn if transversus abdominis plane (TAP) block will reduce the cumulative opioid consumption compared to local wound infiltration (WI). It will also learn about the pain scores compared between TAP and WI groups. Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Transversus Abdominis Plane (TAP) Block, Wound Infiltration, Pain Score (VAS)
- What is being tested?
- TAP group
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteBhutan
- Study dates
- 1 Jan 2023to 31 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- All elective cesarean sections performed under spinal anesthesia,
- American Society of Anesthesiologists physical status classification II (ASA II).
Who cannot join
- Those mothers underwent emergency cesarean section
- Contraindication to spinal anesthesia (increased intracranial pressure, coagulopathy, or local skin infection)
- hypersensitivity to any of the drugs used in the study
- Failed spinal anesthesia converted to general anesthesia
- Pre-existing pain syndromes
- History of recent opioid exposure
- Significant cardiovascular, renal, or hepatic disease,
- Fetal abnormalities or negative fetal outcomes were excluded from the study
Trial locations and contacts
1 site in 1 country.
Bhutan1 site
Yeshey Dorjey
Phuentsholing, Phuentsholing, Chukha, 21001
About this study
Official title: Ultrasound-guided Transversus Abdominis Plane Block Versus Local Wound Infiltration for Postoperative Analgesia After Cesarean Delivery: a Randomized Controlled Trial
The goal of this clinical trial is to learn if transversus abdominis plane (TAP) block will reduce the cumulative opioid consumption compared to local wound infiltration (WI). It will also learn about the pain scores compared between TAP and WI groups. The main questions it aims to answer are:
Has the pain score after cesarean section been less in TAP compared to WI group? Has the cumulative consumption of opioids reduced in TAP as compared to WI group? Researchers will compare TAP group with WI group based on postoperative pain score and opioid used.
Read more
Participants will:
Be given intervention either TAP or WI during the cesarean section. Pain score will be recorded during the postoperative period at PACU, 6, 12 and 24 hours after cesarean section.
The postoperative pain will be rescued with opioid, and the cumulative use of opioids will be recorded.
Read the detailed description
Study title:
Ultrasound-guided Transversus abdominis plane block versus local wound infiltration for postoperative analgesia after cesarean delivery: A randomized controlled trial
Study setting:
Bhutan is a small, landlocked country in the Himalayas, sandwiched between China and India. Its total population is over 0.7 million. 20 Healthcare in Bhutan is publicly owned and solely state-funded. It has a three-tiered health system with the primary health centers at the lowest level followed by district hospitals, regional referral hospitals, and the national referral hospital. 21 Jigme Dorji Wangchuk (JDW) National Referral Hospital is a tertiary referral hospital and a teaching hospital located in the capital city, Thimphu. The Department of Anesthesiology at JDW National Referral Hospital administers anesthesia in eight operation rooms. The department has nine anesthesiologists, eleven nurse anesthetists, seventeen anesthesia technicians, and five residents. The department also has pre-operative and post-anesthesia care unit (PACU) nurses.
In the pre-operative room, pregnant mothers posted for CS are received by the nurses, who complete preoperative documentation and administer prophylactic antibiotics. CS is performed by the resident under the supervision of a consultant or by a consultant obstetrician following a standard procedure under spinal anesthesia. Usually heavy bupivacaine ….mg (2.5ml) with fentanyl …mg (ml) is administered.
After the operation, patients are brought to PACU where the nurses monitor vitals and transfer them to postoperative wards once patients are awake and hemodynamically stable.
Study populations:
Women undergoing elective cesarean section in JDW National Referral Hospital
Inclusion criteria:
All elective cesarean sections performed under spinal anesthesia, with an American Society of Anesthesiologists physical status classification II (ASA II).
Exclusion criteria:
Those mothers underwent emergency cesarean section, contraindication to spinal anesthesia (increased intracranial pressure, coagulopathy, or local skin infection), hypersensitivity to any of the drugs used in the study, failed spinal anesthesia converted to general anesthesia, pre-existing pain syndromes, or with a history of recent opioid exposure, significant cardiovascular, renal, or hepatic disease, and fetal abnormalities or negative fetal outcomes were excluded from the study.
Study period:
The study was carried out from 1st January 2023 till 31st December 2023
Sample size:
The sample size was calculated using the G*Power version 3.1.97 with the following imputations- Test family: 't' tests; Statistical test: 'Mean' differences between two independent means (two groups); Type of power analysis: A priori, computer required sample size. Input parameters: two-tailed test, Type I error (α) = 0.05; Type II error (β) = 0.2; Power = 1-β = 0.8, allocation ratio N2/N1 = 1, and with an effect size (dz) 0.6. The total sample size (n) obtained was 90.
A drop-out rate of 10% was expected, and the total sample taken for the study was 100, divided equally into two groups TAP (n=50) and WI (n=50).
Study Procedure:
An ethical clearance was obtained from the Research Ethical Board of Health, Ministry of Health, Bhutan with Ref No: IRB/Approval/PN/2022-018/ 445, dated 10th November 2022.
All the pregnant mothers posted for elective CS were approached in the pre-operative room by the investigators and obtained written informed consent to participate in the study. Those mothers who voluntarily consented were recruited to the study after applying the inclusion criteria. Those mothers were briefed and familiarised with the visual analogue scale (VAS) for pain scores.
Randomization:
After recruitment, they were allocated into two groups, transversus abdominis plane (TAP) block and local wound infiltration (WI) consisting of 50 participants in each group. Allocation into two groups was done following a lottery system of randomization where each participant was made to pick up one from the basket containing 100 enclosed envelopes which consisted of 50 each for TAP and WI.
Blinding:
A single-blinded study was conducted where the study participants did not know which intervention they received.
In the operating room, patients were attached to anesthetic machines and monitored non-invasively for blood pressure, pulse rate, saturation, and electrocardiogram. All the patients were given intravenous crystalloid solution (Ringers Lactate) at a standard rate. Spinal anesthesia consisting of a preservative-free hyperbaric 0.5% bupivacaine of 1.8ml - 2.2ml was administered intrathecally at the L3 - L4 level using a 27G spinal needle. Failed spinal anesthesia and those converted to general anesthesia were excluded from the study.
After attaining an upper sensory level of T6 or higher, a standard CS with a Pfannenstiel incision was performed by the resident under supervision or by a consultant obstetrician. After the delivery of the baby, participants in both groups received oxytocin (30 units) through infusion and intravenous paracetamol (15mg/kg). Intraoperative complications were managed following the same protocol for both groups; bradycardia and hypotension were treated with inj ephedrine (….), and nausea/vomiting were managed inj metoclopramide (10mg).
Intervention:
In the TAP group, after completion of CS, the anesthesiologist performed a bilateral TAP block. The dividing screen was kept in place and the skin was cleaned with a 10% betadine solution. Under sterile precautions, using a linear ultrasound probe placed over the mid-axillary line at the midpoint between the costal margin and the iliac crest, the external oblique, internal oblique, and transversus abdominis muscles were identified. A 20 G nerve block needle was advanced under direct ultrasound vision through the skin, subcutaneous tissues, external oblique, and internal oblique, and once the needle tip reached the space between the internal oblique and the transversus abdominis muscle, a 20 ml of 0.25% bupivacaine was injected. A well-defined, hypoechoic, elliptical shape formation confirmed the correct site of injection. The same procedure was performed on the other side.
In Group WI, the local anesthetic wound infiltration was performed by the operating obstetrician. Before the skin closure, 20 ml of 0.25% bupivacaine was injected subcutaneously along the full length including both the upper and lower margins of the wound. The dividing screen was kept in place so the patient could not determine which pain intervention was being offered to them.
After the intervention following CS, participants were taken to the PACU and monitored for vitals. In the PACU, pain scores were assessed using the VAS by the investigators, and the postoperative complications including nausea, vomiting, pruritus, and the additional medications required in the PACU were recorded.
After they were shifted to the maternity ward, trained maternity nurses who were not a part of the study and unaware of the treatment modality, monitored and recorded the pain score, opioid consumption, and side effects at 6, 12, and 24 hours according to the questionnaire that was handed in the patient's file. Postoperative rescue analgesia was given according to the standard institute obstetricians protocol with scheduled oral paracetamol and intramuscular diclofenac sodium injections with on demand opioids (pethidine/tramadol/morphine). Ondansetron intravenous was offered for nausea and vomiting.
Study end-points:
Primary end-point was opioids consumption in the first 24hour after cesarean section.
Secondary end-point was VAS pain score (0-10) and side effects like post operative nausea, vomiting, sedation, and complications related to the procedure.
Data analysis:
Data were double-entered and validated using EpiData (version 3.1 for entry and version 2.2.2.183 for analysis, EpiData Association, Odense, Denmark). Data were exported and analyzed using SPSS (version 23). The Kolmogorov-Smirnov test was performed to test for the normality of the study data. Normally distributed continuous demographic and clinical characteristics variables were compared using student t-test. Non-normally distributed two independent variables were compared using Mann-Whitney test. The Chi square or Fisher's exact test was used to analyze categorical variables and presented in frequencies and percentages. The p-value of \< 0.05 is considered statistically significant in the study.
- Conditions
- Transversus Abdominis Plane (TAP) Block, Wound Infiltration, Pain Score (VAS), Opioid Analgesia
- Being tested
- TAP group
- Keywords
- transversus abdominis plane block, Wound infiltration of local anesthesia, pain score, Opioid analgesia, cesarean section
- Medical subject headings
- Bites and Stings
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TAP groupProcedure or surgery
Local anesthesia 0.25% bupivacine was administered in the TAP plane
| Study group | Role | What they receive |
|---|---|---|
| TAP group | Experimental | Local anesthesia 0.25% bupivacine 20ml was administered at the transversus abdominis plane in TAP group (experiment) Receives: Procedure: TAP group |
| WI group | Active comparator | Local anesthesia 0.25% bupivacine 20ml was administered or infiltrated along the cesarean wound in WI group as a an active comparator Receives: Procedure: TAP group |
What is being measured
The primary outcome is the main question the study is designed to answer.
To compare cumulative consumption of opioids in the first 24 hours after cesarean section
Cumulative use of Inj. morphine during the postoperative period was significantly less in the TAP group than in the WI group (5.4 ± 0.9 Vs 6.1 ± 0.6, p=0.017)
Measured: within 24 hours postoperative period
Secondary outcomes (2)
To compare the pain score using the Visual Analogue Scale between the intervention (TAP) and comparator (WI) group
The postoperative pain score was significantly lower in the intervention (TAP) group where patients received ultrasound-guided transversus abdominis plane block as compared to a comparative (WI) group who received wound infiltration of local anesthesia (0.62 ± 0.87 Vs 1.22 ± 1.44 respectively, p-value 0.013) at the post-anesthesia care unit (PACU).
Measured: within 6, 12 and 24 hours postoperative period
To compare the postoperative complications between the intervention (TAP) group with the comparator (WI) group.
Postoperative complications were reported in over 15% (15/99) of the patients. Postoperative complications reported were less in the experimental (TAP) group as compared to the WI group.
Measured: Within first 24 hours postoperative period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Oct 2024
- Study start1 Jan 2023
- Primary completion31 Dec 2023
- Study completion31 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Transversus Abdominis Plane (TAP) BlockStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ministry of Health, Bhutan
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Yeshey Dorjey, MD, Principal investigator, Phuentsholing General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06627946
- Sponsor's protocol ID
- 445
- Other IDs
- TAPStudy
- Acronym
- TAP
- Status last verified
- Sep 2024
- First submitted
- 20 Sep 2024
- Last updated
- 4 Oct 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ultrasound-guided Transversus Abdominis Plane Block Versus Local Wound Infiltration for Postoperative Analgesia After Cesarean Delivery: a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06627946
- Acronym / sponsor ID
- TAP / 445
- Conditions
- Transversus Abdominis Plane (TAP) Block, Wound Infiltration, Pain Score (VAS), Opioid Analgesia
- Keywords
- transversus abdominis plane block, Wound infiltration of local anesthesia, pain score, Opioid analgesia, cesarean section
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Ministry of Health, BhutanOther government
- Study start
- 1 Jan 2023 (actual)
- Primary completion
- 31 Dec 2023 (actual)
- Study completion
- 31 Dec 2023 (actual)
- First posted
- 4 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if transversus abdominis plane (TAP) block will reduce the cumulative opioid consumption compared to local wound infiltration (WI). It will also learn about the pain scores compared between TAP and WI groups. The main questions it aims to answer are:
Has the pain score after cesarean section been less in TAP compared to WI group? Has the cumulative consumption of opioids reduced in TAP as compared to WI group? Researchers will compare TAP group with WI group based on postoperative pain score and opioid used.
Participants will:
Be given intervention either TAP or WI during the cesarean section. Pain score will be recorded during the postoperative period at PACU, 6, 12 and 24 hours after cesarean section.
The postoperative pain will be rescued with opioid, and the cumulative use of opioids will be recorded.
Detailed description
Study title:
Ultrasound-guided Transversus abdominis plane block versus local wound infiltration for postoperative analgesia after cesarean delivery: A randomized controlled trial
Study setting:
Bhutan is a small, landlocked country in the Himalayas, sandwiched between China and India. Its total population is over 0.7 million. 20 Healthcare in Bhutan is publicly owned and solely state-funded. It has a three-tiered health system with the primary health centers at the lowest level followed by district hospitals, regional referral hospitals, and the national referral hospital. 21 Jigme Dorji Wangchuk (JDW) National Referral Hospital is a tertiary referral hospital and a teaching hospital located in the capital city, Thimphu. The Department of Anesthesiology at JDW National Referral Hospital administers anesthesia in eight operation rooms. The department has nine anesthesiologists, eleven nurse anesthetists, seventeen anesthesia technicians, and five residents. The department also has pre-operative and post-anesthesia care unit (PACU) nurses.
In the pre-operative room, pregnant mothers posted for CS are received by the nurses, who complete preoperative documentation and administer prophylactic antibiotics. CS is performed by the resident under the supervision of a consultant or by a consultant obstetrician following a standard procedure under spinal anesthesia. Usually heavy bupivacaine ….mg (2.5ml) with fentanyl …mg (ml) is administered.
After the operation, patients are brought to PACU where the nurses monitor vitals and transfer them to postoperative wards once patients are awake and hemodynamically stable.
Study populations:
Women undergoing elective cesarean section in JDW National Referral Hospital
Inclusion criteria:
All elective cesarean sections performed under spinal anesthesia, with an American Society of Anesthesiologists physical status classification II (ASA II).
Exclusion criteria:
Those mothers underwent emergency cesarean section, contraindication to spinal anesthesia (increased intracranial pressure, coagulopathy, or local skin infection), hypersensitivity to any of the drugs used in the study, failed spinal anesthesia converted to general anesthesia, pre-existing pain syndromes, or with a history of recent opioid exposure, significant cardiovascular, renal, or hepatic disease, and fetal abnormalities or negative fetal outcomes were excluded from the study.
Study period:
The study was carried out from 1st January 2023 till 31st December 2023
Sample size:
The sample size was calculated using the G*Power version 3.1.97 with the following imputations- Test family: 't' tests; Statistical test: 'Mean' differences between two independent means (two groups); Type of power analysis: A priori, computer required sample size. Input parameters: two-tailed test, Type I error (α) = 0.05; Type II error (β) = 0.2; Power = 1-β = 0.8, allocation ratio N2/N1 = 1, and with an effect size (dz) 0.6. The total sample size (n) obtained was 90.
A drop-out rate of 10% was expected, and the total sample taken for the study was 100, divided equally into two groups TAP (n=50) and WI (n=50).
Study Procedure:
An ethical clearance was obtained from the Research Ethical Board of Health, Ministry of Health, Bhutan with Ref No: IRB/Approval/PN/2022-018/ 445, dated 10th November 2022.
All the pregnant mothers posted for elective CS were approached in the pre-operative room by the investigators and obtained written informed consent to participate in the study. Those mothers who voluntarily consented were recruited to the study after applying the inclusion criteria. Those mothers were briefed and familiarised with the visual analogue scale (VAS) for pain scores.
Randomization:
After recruitment, they were allocated into two groups, transversus abdominis plane (TAP) block and local wound infiltration (WI) consisting of 50 participants in each group. Allocation into two groups was done following a lottery system of randomization where each participant was made to pick up one from the basket containing 100 enclosed envelopes which consisted of 50 each for TAP and WI.
Blinding:
A single-blinded study was conducted where the study participants did not know which intervention they received.
In the operating room, patients were attached to anesthetic machines and monitored non-invasively for blood pressure, pulse rate, saturation, and electrocardiogram. All the patients were given intravenous crystalloid solution (Ringers Lactate) at a standard rate. Spinal anesthesia consisting of a preservative-free hyperbaric 0.5% bupivacaine of 1.8ml - 2.2ml was administered intrathecally at the L3 - L4 level using a 27G spinal needle. Failed spinal anesthesia and those converted to general anesthesia were excluded from the study.
After attaining an upper sensory level of T6 or higher, a standard CS with a Pfannenstiel incision was performed by the resident under supervision or by a consultant obstetrician. After the delivery of the baby, participants in both groups received oxytocin (30 units) through infusion and intravenous paracetamol (15mg/kg). Intraoperative complications were managed following the same protocol for both groups; bradycardia and hypotension were treated with inj ephedrine (….), and nausea/vomiting were managed inj metoclopramide (10mg).
Intervention:
In the TAP group, after completion of CS, the anesthesiologist performed a bilateral TAP block. The dividing screen was kept in place and the skin was cleaned with a 10% betadine solution. Under sterile precautions, using a linear ultrasound probe placed over the mid-axillary line at the midpoint between the costal margin and the iliac crest, the external oblique, internal oblique, and transversus abdominis muscles were identified. A 20 G nerve block needle was advanced under direct ultrasound vision through the skin, subcutaneous tissues, external oblique, and internal oblique, and once the needle tip reached the space between the internal oblique and the transversus abdominis muscle, a 20 ml of 0.25% bupivacaine was injected. A well-defined, hypoechoic, elliptical shape formation confirmed the correct site of injection. The same procedure was performed on the other side.
In Group WI, the local anesthetic wound infiltration was performed by the operating obstetrician. Before the skin closure, 20 ml of 0.25% bupivacaine was injected subcutaneously along the full length including both the upper and lower margins of the wound. The dividing screen was kept in place so the patient could not determine which pain intervention was being offered to them.
After the intervention following CS, participants were taken to the PACU and monitored for vitals. In the PACU, pain scores were assessed using the VAS by the investigators, and the postoperative complications including nausea, vomiting, pruritus, and the additional medications required in the PACU were recorded.
After they were shifted to the maternity ward, trained maternity nurses who were not a part of the study and unaware of the treatment modality, monitored and recorded the pain score, opioid consumption, and side effects at 6, 12, and 24 hours according to the questionnaire that was handed in the patient's file. Postoperative rescue analgesia was given according to the standard institute obstetricians protocol with scheduled oral paracetamol and intramuscular diclofenac sodium injections with on demand opioids (pethidine/tramadol/morphine). Ondansetron intravenous was offered for nausea and vomiting.
Study end-points:
Primary end-point was opioids consumption in the first 24hour after cesarean section.
Secondary end-point was VAS pain score (0-10) and side effects like post operative nausea, vomiting, sedation, and complications related to the procedure.
Data analysis:
Data were double-entered and validated using EpiData (version 3.1 for entry and version 2.2.2.183 for analysis, EpiData Association, Odense, Denmark). Data were exported and analyzed using SPSS (version 23). The Kolmogorov-Smirnov test was performed to test for the normality of the study data. Normally distributed continuous demographic and clinical characteristics variables were compared using student t-test. Non-normally distributed two independent variables were compared using Mann-Whitney test. The Chi square or Fisher's exact test was used to analyze categorical variables and presented in frequencies and percentages. The p-value of \< 0.05 is considered statistically significant in the study.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| TAP group | Experimental | Procedure: TAP groupLocal anesthesia 0.25% bupivacine 20ml was administered at the transversus abdominis plane in TAP group (experiment) |
| WI group | Active comparator | Procedure: TAP groupLocal anesthesia 0.25% bupivacine 20ml was administered or infiltrated along the cesarean wound in WI group as a an active comparator |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- All elective cesarean sections performed under spinal anesthesia,
- American Society of Anesthesiologists physical status classification II (ASA II).
Key exclusion criteria (8 listed)
- Those mothers underwent emergency cesarean section
- Contraindication to spinal anesthesia (increased intracranial pressure, coagulopathy, or local skin infection)
- hypersensitivity to any of the drugs used in the study
- Failed spinal anesthesia converted to general anesthesia
- Pre-existing pain syndromes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TAP groupLocal anesthesia 0.25% bupivacine was administered in the TAP plane | Procedure or surgery | TAP group, WI group |
Primary outcome
To compare cumulative consumption of opioids in the first 24 hours after cesarean section
Time frame: within 24 hours postoperative period
Cumulative use of Inj. morphine during the postoperative period was significantly less in the TAP group than in the WI group (5.4 ± 0.9 Vs 6.1 ± 0.6, p=0.017)
2 secondary outcomes
To compare the pain score using the Visual Analogue Scale between the intervention (TAP) and comparator (WI) group
Time frame: within 6, 12 and 24 hours postoperative period
To compare the postoperative complications between the intervention (TAP) group with the comparator (WI) group.
Time frame: Within first 24 hours postoperative period
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Oct 2024.
- Individual participant dataSharing planned: No
Related trials for Transversus Abdominis Plane (TAP) Block
Active, not recruiting
Efficacy of Laparoscopic-Assisted TAP Block in Laparoscopic Appendectomy
Appendectomy, Laparoscopic, Blockades Neuromuscular
Not yet recruiting
Lumbar ESP Block Versus TAP Block for Postoperative Pain Control in Children Undergoing Open Inguinal Hernia Repair
Inguinal Hernia, Postoperative Pain
Not yet recruiting
Subcostal TAP Block Versus Combined Subcostal TAP and Recto-Intercostal Fascial Plane Block for Analgesia After Laparoscopic Cholecystectomy
Laparoscopic Cholecystectomy, Postoperative Pain
Recruiting
Spinal Anesthesia Versus General Anesthesia Plus TAP Block for Laparoscopic Inguinal Hernia Repair
Transversus Abdominis Plane Block (TAP Block), Laparoscopic Inguinal Hernia Repair
Not yet recruiting
TAP vs. ESP Blocks for Post-Cesarean Analgesia
Postoperative Pain After Cesarean Section
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yeshey Dorjey, MD principal investigator
Phuentsholing General Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing TAP group in people with Transversus Abdominis Plane (TAP) Block and Wound Infiltration, run by Ministry of Health, Bhutan at 1 site in Bhutan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Bhutan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To compare cumulative consumption of opioids in the first 24 hours after cesarean section (time frame: within 24 hours postoperative period). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2024.